Kakimoto M - Search Results

1

In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract.

Kakimoto M, Nomura T, Nazmul T, Yamamoto A, Sasaki H, Higashiura A, Ito M, Ohge H, Mikage M, Ogawa KO, Sakaguchi T. Kakimoto M, et al. J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117341. doi: 10.1016/j.jep.2023.117341. Epub 2023 Oct 23. J Ethnopharmacol. 2024. PMID: 37879507 Free article.

2

Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats.

Kakimoto M, Fujii M, Sato I, Honma K, Nakayama H, Kirihara S, Fukuoka T, Ran S, Hirohata S, Kitamori K, Yamamoto S, Watanabe S. Kakimoto M, et al. J Appl Biomed. 2023 Jun;21(2):80-90. doi: 10.32725/jab.2023.009. Epub 2023 May 22. J Appl Biomed. 2023. PMID: 37376883 Free article.

3

Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.

Yamamoto S, Sato I, Fujii M, Kakimoto M, Honma K, Kirihara S, Nakayama H, Fukuoka T, Tamura S, Ueda M, Hirohata S, Watanabe S. Yamamoto S, et al. Among authors: kakimoto m. Can J Physiol Pharmacol. 2023 Sep 1;101(9):455-465. doi: 10.1139/cjpp-2022-0532. Epub 2023 May 24. Can J Physiol Pharmacol. 2023. PMID: 37224568

4

SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.

Yamamoto S, Honma K, Fujii M, Kakimoto M, Kirihara S, Nakayama H, Kitamori K, Sato I, Hirohata S, Watanabe S. Yamamoto S, et al. Among authors: kakimoto m. Ann Anat. 2023 Aug;249:152104. doi: 10.1016/j.aanat.2023.152104. Epub 2023 May 18. Ann Anat. 2023. PMID: 37209870

5

Increased Glycine-conjugated and Unconjugated Bile Acid Levels Associated with Aggravation of Nonalcoholic Steatohepatitis and Cardiovascular Disease in SHRSP5/Dmcr Rat.

Yamamoto S, Sato I, Fujii M, Kakimoto M, Honma K, Akiyama N, Sakai M, Fukuhama N, Kumazaki S, Hirohata S, Kitamori K, Yamori Y, Watanabe S. Yamamoto S, et al. Among authors: kakimoto m. Acta Med Okayama. 2023 Feb;77(1):29-36. doi: 10.18926/AMO/64358. Acta Med Okayama. 2023. PMID: 36849143 Free article.

6

Impact of the early phase of COVID-19 on the trends of isolated bacteria in the national database of Japan: an interrupted time-series analysis.

Kakimoto M, Miyamori D, Omori K, Kobayashi T, Ikeda K, Kashiyama S, Ohge H, Ito M. Kakimoto M, et al. J Infect. 2023 Feb;86(2):147-153. doi: 10.1016/j.jinf.2022.11.025. Epub 2022 Dec 2. J Infect. 2023. PMID: 36463984 Free PMC article.

7

Viable SARS-CoV-2 detected in the air of hospital rooms of patients with COVID-19 with an early infection.

Kitagawa H, Nomura T, Kaiki Y, Kakimoto M, Nazmul T, Omori K, Shigemoto N, Sakaguchi T, Ohge H. Kitagawa H, et al. Among authors: kakimoto m. Int J Infect Dis. 2023 Jan;126:73-78. doi: 10.1016/j.ijid.2022.11.003. Epub 2022 Nov 8. Int J Infect Dis. 2023. PMID: 36356797 Free PMC article.

8

Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot Trial.

Hamada H, Sekikawa K, Okusaki K, Dodo T, Kagawa K, Sumigawa T, Awaya Y, Sakimoto N, Shioya S, Hakozaki K, Kadowaki T, Kakimoto M, Ito R, Kawamichi K, Kondo K, Namba H, Iwamoto H, Hattori N. Hamada H, et al. Among authors: kakimoto m. J Clin Med. 2022 Sep 26;11(19):5673. doi: 10.3390/jcm11195673. J Clin Med. 2022. PMID: 36233538 Free PMC article.

9

Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.

Sato I, Yamamoto S, Kakimoto M, Fujii M, Honma K, Kumazaki S, Matsui M, Nakayama H, Kirihara S, Ran S, Usui S, Shinohata R, Kitamori K, Hirohata S, Watanabe S. Sato I, et al. Among authors: kakimoto m. Pharmacol Rep. 2022 Aug;74(4):669-683. doi: 10.1007/s43440-022-00380-1. Epub 2022 Jul 12. Pharmacol Rep. 2022. PMID: 35819592

10

In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms.

Kakimoto M, Nomura T, Nazmul T, Kitagawa H, Kanno K, Ogawa-Ochiai K, Ohge H, Ito M, Sakaguchi T. Kakimoto M, et al. Front Pharmacol. 2022 Mar 29;13:804103. doi: 10.3389/fphar.2022.804103. eCollection 2022. Front Pharmacol. 2022. PMID: 35422704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page